ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 24,007 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.10p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 2476 to 2497 of 8600 messages
Chat Pages: Latest  104  103  102  101  100  99  98  97  96  95  94  93  Older
DateSubjectAuthorDiscuss
22/2/2018
07:32
remarkomsoc, you mean the difference between N4P's Nuvec and the current lipid / nanoparticle drug method?

N4P's CEO said this last November (link below) and an additional study highlighting the differences is awaited as well:-




For Nuvec :- Non in-vito toxicity (tested in animals & humans), no unwanted inflammatory responses, provides high DNA loading capacity, protection of DNA from enzymes, delivery of large nucleic acids in-vivo studies. : not so for any of that list current lipid / nanoparticle system

Pharmas are currently using lipid / nanoparticles but “many problems”

Nuvec :- Uniquely designed to work with the shape & structure of DNA / RNA : not so for current lipid / nanoparticle system

Nuvec :- Can get a lot more DNA / RNA loaded. A really high level of DNA loaded and bound on its way to the cell. An incredibly high amount.

Nuvec :- “Don't get much falling off with around 95% reaching it's target - with lipid / nanoparticle system as little as 10% can reach the target.

Falling off with lipid / nanoparticle system ends up with unwanted Immunotherapy effect.

“You want the DNA to do its thing in the cell you don't want it floating around the rest of the body ending up in the wrong place.”

Nuvec: “clever design”

Nuvec :- “Not difficult to make. Not a hugely expensive manufacturing process. Very,very well placed when we start taking it to market”

Nuvec :- “Can probably deliver 4 or 5 DNA / RNA strings at the same time. Another key benefit in the delivery.”

nick2412
21/2/2018
22:49
These are the organizations represented at Thursdays meeting.
hughwilson
21/2/2018
22:30
Thursday it is then:
hughwilson
21/2/2018
22:06
Staggering potential here, i dont have as many as some, but there is no way under the sun i will be letting these go at this price.
escapetohome
21/2/2018
21:43
Take care mate.
cryptotrade
21/2/2018
21:13
To be upfront, I bought in mid 28, and 32, But researched the company in advance. Lots of folk were ranting about the increase, potential but I held off, missed my entry . However My moniker doesn't contradict how I invest. But I wish you the best, and he'll yeah this will be a rollercoaster, and hope your earn. Gla.
l0ngterm
21/2/2018
21:06
Long-term, no worries. Best of luck. Happy for you all who have stock at 5/10p. Great buy.
cryptotrade
21/2/2018
21:05
You suck it Vols.
cryptotrade
21/2/2018
21:05
No offence meant, I do admire your style, and honesty. We are invested here because we see a rise, you might wish to play the surf in between. But now we are clear, we will understand each other.
l0ngterm
21/2/2018
21:03
I like plates with food, you have a point demonstrating a lazy approach. Still, I'll watch the plate next time.

25p it is.

cryptotrade
21/2/2018
21:02
Why bother reading when I can challenge you, and you put it on a plate.
l0ngterm
21/2/2018
21:00
No problems. It was clear at the start. It's obvious if you read it all. Questioning is one thing, not reading the original posts is another.

Onwards and upwards.

cryptotrade
21/2/2018
20:56
that's better crypto, you have clarified your position. You wish to trade brilliant. You have a technical analysis. As for me questioning, it's a public board if you don't want challenged, or to share your thoughts , then don't post publicly. We have now move forward, you want in and wish to take up a position. Thanks for confirming.
l0ngterm
21/2/2018
20:35
Sorry just to clarify: you basically state don't trust what people say on boards ( get it )Then follow up with 25p (without a technically analysis, supporting info etc) Don't get it, why bother?But your are following the share. So basically, all I can can deduce is that you want to buy (otherwise why follow, comment). But you want to buy at 0.25p!Or did I miss something?
l0ngterm
21/2/2018
20:14
Sorry can you please clarify your statements. As there are sweeping generalisations across the comments made? Even more so, one comment one cancels the other out!
l0ngterm
21/2/2018
13:29
Parob, only time seperates us from three figures, and not a lot of it either.
hughwilson
21/2/2018
10:55
Lucky I didn't take the advice and buy at 35p. I'd be 20% down.

You never know it may retest 25p or maybe, just maybe stock is needed so a decent shake is coming. nothing wrong with that.

cryptotrade
21/2/2018
10:52
Courtesy of Nick posted over on lse:More importantly for buy and hold shareholders are these questions (listed below) rather than whether 30 .12321 is resistance or 29.455737373 is support :- 1) Have N4P in the form of Nuvec got a vastly superior DNA drug delivery system for use in multi billion $ markets that is going to be taken up by the likes of Medimmune / AZ and become an industry standard? 2) Have N4P got a superior patented form of off patent Viagra with excellent existing safety data and good near-term (in pharma timescales) prospects to be licensed out with a downpayment milestone that exceeds the current market cap and bring in 10% plus royalties for its share of a multi-billion market? 3) Can N4P fast track to FDA approval? 4) Have N4P got a conveyor belt of similar prospects including some tackling bigger markets? 5) Is all of this incredibly low cost, reasonably near-term and lower risk given the existing safety data for the reformulations? If the answer is yes to these questions (and I believe all suggest a resounding yes) then, as some have already said, N4P will be valued in pounds not pence. It's my belief that this is one of those stocks where those who just hold their stock rather than trade for a penny here and there will benefit most. N4P do also put out intra-day announcements when appropriate. I'm keenly awaiting newsflow on Nuvec differentiation, Slidanifil results and potential news additional collaborations for Nuvec.
parob
21/2/2018
10:14
£10 today
cryptotrade
21/2/2018
09:41
Eddie

"The emphasis on this trip is to form collaborations"

Collaborations lead to deals.

hughwilson
21/2/2018
09:33
Hugh I think you will find that it's you that's wrong old bean
Take a look below to jog your poor memory

hughwilson
9 Feb '18 - 15:27 - 1964 of 2404
The emphasis on this trip is to form collaborations and sign deals.
I am EXPECTING very positive news from the trip.


Eddie_Yates
9 Feb '18 - 16:17 - 1965 of 2404 Edit
Do you mean hoping for Hugh?


hughwilson
9 Feb '18 - 16:25 - 1966 of 2404
No, I mean EXPECTING.

eddie_yates
21/2/2018
09:15
Eddie, you are wrong as per usual.
What I actually said was that logic would say that we would have news. I have always said that deals were possible but that collaborations were more likely.

hughwilson
Chat Pages: Latest  104  103  102  101  100  99  98  97  96  95  94  93  Older

Your Recent History

Delayed Upgrade Clock